Hypertension and Acromegaly

• Autores: Soraya Puglisi, Massimo Terzolo
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 48, Nº. 4, 2019 (Ejemplar dedicado a: Endocrine Hypertension), págs. 779-793
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Hypertension is one of the most frequent complications in acromegaly, with a median frequency of 33.6% (range, 11%–54.7%). Although the pathogenesis has not been fully elucidated, it probably results from concomitant factors leading to expansion of extracellular fluid volume, increase of peripheral vascular resistance, and development of sleep apnea syndrome. Because the effect of normalization of growth hormone and insulinlike growth factor 1 excess on blood pressure levels is unclear, an early diagnosis of hypertension and prompt antihypertensive treatment are eagerly recommended, regardless of the specific treatment of the acromegalic disease and the level of biochemical control attained.